BioNexus KC Highlights Children's Mercy Researchers
The Kansas City region is a global leader at the nexus of human and animal health science. The mission of BioNexus KC is to "inspire thinkers from different disciplines to combine their efforts for a common purpose – healthcare innovation. From bioinformatics to cancer research and beyond, we stimulate collaboration and help bring emerging technologies from concept to reality."
The BioNexus Expert Exchange features regional researchers with advanced medical breakthroughs. Tom Curran, PhD, FRS, Executive Director of the Children's Research Institute at Children's Mercy and Mark Clements, MD, PhD, Endocrinology and Diabetes, are both featured in video interviews as part of the Expert Exchange series.
Mark Clements, MD, PhD
Technology-Enabled Pediatric Diabetes Management
Tom Curran, PhD, FRS
Children's Mercy Director Moving Kids with Brain Tumors to the Front of the Line
Children’s Mercy Kansas City is an independent, non-profit, 390-bed pediatric health system, providing over half a million patient encounters each year for children from across the country. Children’s Mercy is ranked by U.S. News & World Report in all ten specialties. We have received Magnet® recognition five times for excellence in nursing services. In affiliation with the University of Missouri-Kansas City, our faculty of nearly 800 pediatric specialists and researchers is actively involved in clinical care, pediatric research and educating the next generation of pediatricians and pediatric subspecialists. The Children’s Mercy Research Institute (CMRI) integrates research and clinical care with nationally recognized expertise in genomic medicine, precision therapeutics, population health, health care innovation and emerging infections. In 2021 the CMRI moved into a nine-story, 375,000-square-foot space emphasizing a translational approach to research in which clinicians and researchers work together to accelerate the pace of discovery that enhances care.